Abstract
Ectopic overexpression of the murine agouti gene results in yellow coat color, obesity, hyperinsulinemia, and type II diabetes. We have shown the human homologue of agouti (agouti signaling protein; ASP) to regulate human adipocyte metabolism and lipid storage via a Ca2+-dependent mechanism. We have also demonstrated agouti expression in human pancreas, and that ASP stimulates insulin release via a similar Ca2+-dependent mechanism. Plasma amylin is also elevated in agouti mutant mice. Amylin is cosecreted with insulin from β-cells, and overexpression of human amylin in β-cells in yellow agouti mutant mice resulted in accelerated pancreatic amyloid deposition, severely impaired β-cell function, and a diabetic phenotype. We report here that ASP stimulates amylin release in both the HIT-T15 β-cell line and human pancreatic islets in the presence of a wide range of glucose concentrations (0–16.7 mmol/L), similar to its effect on insulin release; this effect was blocked by 30 μmol/L nitrendipine, confirming a Ca2+-dependent mechanism. Accordingly, ASP stimulation of amylin release may serve as a compensatory system to regulate blood glucose in yellow agouti mutants.
Get full access to this article
View all access options for this article.
